Atomistry » Fluorine » PDB 1o5g-1q6m » 1pxl
Atomistry »
  Fluorine »
    PDB 1o5g-1q6m »
      1pxl »

Fluorine in PDB 1pxl: Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine

Protein crystallography data

The structure of Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine, PDB code: 1pxl was solved by S.Y.Wu, I.Mcnae, G.Kontopidis, S.J.Mcclue, C.Mcinnes, K.J.Stewart, S.Wang, D.I.Zheleva, H.Marriage, D.P.Lane, P.Taylor, P.M.Fischer, M.D.Walkinshaw, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 16.47 / 2.50
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 52.709, 71.575, 70.429, 90.00, 90.00, 90.00
R / Rfree (%) 20.4 / 24.9

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine (pdb code 1pxl). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine, PDB code: 1pxl:
Jump to Fluorine binding site number: 1; 2; 3;

Fluorine binding site 1 out of 3 in 1pxl

Go back to Fluorine Binding Sites List in 1pxl
Fluorine binding site 1 out of 3 in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F500

b:58.9
occ:0.59
F8B A:CK4500 0.0 58.9 0.6
C7B A:CK4500 1.4 58.1 0.6
F1B A:CK4500 2.3 58.1 0.6
F9B A:CK4500 2.3 58.6 0.6
C4B A:CK4500 2.4 56.1 0.6
C3B A:CK4500 2.9 55.9 0.6
O A:ILE10 3.5 78.3 1.0
C5B A:CK4500 3.7 55.6 0.6
OD2 A:ASP86 4.1 37.4 1.0
C2B A:CK4500 4.3 54.9 0.6
CE A:LYS89 4.4 64.6 1.0
C A:ILE10 4.7 77.3 1.0
C6B A:CK4500 4.8 54.4 0.6
CG A:ASP86 5.0 36.7 1.0

Fluorine binding site 2 out of 3 in 1pxl

Go back to Fluorine Binding Sites List in 1pxl
Fluorine binding site 2 out of 3 in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F500

b:58.1
occ:0.59
F1B A:CK4500 0.0 58.1 0.6
C7B A:CK4500 1.4 58.1 0.6
F8B A:CK4500 2.3 58.9 0.6
F9B A:CK4500 2.3 58.6 0.6
C4B A:CK4500 2.5 56.1 0.6
C5B A:CK4500 2.9 55.6 0.6
C3B A:CK4500 3.8 55.9 0.6
CE A:LYS89 3.9 64.6 1.0
CG A:LYS89 4.2 54.3 1.0
C6B A:CK4500 4.3 54.4 0.6
CD A:LYS89 4.4 62.0 1.0
O A:HOH532 4.5 43.3 1.0
CB A:LYS89 4.7 49.4 1.0
NZ A:LYS89 4.9 66.4 1.0
C2B A:CK4500 5.0 54.9 0.6

Fluorine binding site 3 out of 3 in 1pxl

Go back to Fluorine Binding Sites List in 1pxl
Fluorine binding site 3 out of 3 in the Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Human Cyclin Dependent Kinase 2 Complexed with the Inhibitor [4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- (4-Trifluoromethyl-Phenyl)-Amine within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F500

b:58.6
occ:0.59
F9B A:CK4500 0.0 58.6 0.6
C7B A:CK4500 1.4 58.1 0.6
F8B A:CK4500 2.3 58.9 0.6
F1B A:CK4500 2.3 58.1 0.6
C4B A:CK4500 2.5 56.1 0.6
OD2 A:ASP86 3.0 37.4 1.0
CE A:LYS89 3.1 64.6 1.0
C3B A:CK4500 3.3 55.9 0.6
CB A:LYS89 3.3 49.4 1.0
OD1 A:ASP86 3.4 36.0 1.0
CG A:ASP86 3.4 36.7 1.0
C5B A:CK4500 3.4 55.6 0.6
CG A:LYS89 3.5 54.3 1.0
CD A:LYS89 3.9 62.0 1.0
NZ A:LYS89 4.2 66.4 1.0
CA A:LYS89 4.5 45.7 1.0
C2B A:CK4500 4.5 54.9 0.6
N A:ASP86 4.6 36.9 1.0
C6B A:CK4500 4.7 54.4 0.6
CB A:ASP86 4.7 37.1 1.0
N A:LYS89 4.8 45.7 1.0

Reference:

S.Y.Wu, I.Mcnae, G.Kontopidis, S.J.Mcclue, C.Mcinnes, K.J.Stewart, S.Wang, D.I.Zheleva, H.Marriage, D.P.Lane, P.Taylor, P.M.Fischer, M.D.Walkinshaw. Discovery of A Novel Family of Cdk Inhibitors with the Program Lidaeus: Structural Basis For Ligand-Induced Disordering of the Activation Loop Structure V. 11 399 2003.
ISSN: ISSN 0969-2126
PubMed: 12679018
DOI: 10.1016/S0969-2126(03)00060-1
Page generated: Wed Jul 31 12:22:27 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy